Source:http://linkedlifedata.com/resource/pubmed/id/17966040
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2007-10-29
|
pubmed:abstractText |
Proteinase 3 (PR3)-specific antineutrophil cytoplasmic autoantibodies (PR3-ANCA) recognize conformational epitopes on PR3. This study evaluates PR3-ANCA target epitopes utilizing a novel recombinant PR3 (rPR3) produced to accommodate manipulations of the N-terminal domain. The rPR3 molecule contains an N-terminus six histidine tag, which can be removed by enterokinase (EK) cleavage of an adjacent EK cleavage site. Once cleaved the remaining amino acids correspond to the mature N-terminus of PR3. This rPR3 can be manipulated to produce three variant forms: tagged rPR3(+his), EK-cleaved (his-tag removed) rPR3(- his), and EK-cleaved, denatured/refolded rPR3(- his/dr) (the proteolytically active form). Patients with clinically positive PR3-ANCA titers (n = 40) were confirmed for reactivity against purchased native PR3 in our system. Controls included 29 healthy volunteers and 34 MPO-ANCA patients. All PR3-ANCA sera samples tested were reactive with one or more forms of the recombinant protein (greater than mean ELISA OD 405 + 2 SDs of controls). Of significance, three sera were reactive with non-active forms only and three others were more reactive with rPR3(- his/dr) than with native PR3. The results of our evaluation of PR3-ANCA sera for reactivity against the three forms of our rPR3 protein uniquely exemplify the diverse array of epitopes within the PR3-ANCA population. This new recombinant form of PR3 should provide a suitable approach to mapping ANCA epitopes using site-directed mutagenesis.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Antineutrophil...,
http://linkedlifedata.com/resource/pubmed/chemical/Enteropeptidase,
http://linkedlifedata.com/resource/pubmed/chemical/Epitopes,
http://linkedlifedata.com/resource/pubmed/chemical/Histidine,
http://linkedlifedata.com/resource/pubmed/chemical/Myeloblastin,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/polyhistidine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1607-842X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
503-11
|
pubmed:meshHeading |
pubmed-meshheading:17966040-Antibodies, Antineutrophil Cytoplasmic,
pubmed-meshheading:17966040-Enteropeptidase,
pubmed-meshheading:17966040-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:17966040-Epitope Mapping,
pubmed-meshheading:17966040-Epitopes,
pubmed-meshheading:17966040-Female,
pubmed-meshheading:17966040-Histidine,
pubmed-meshheading:17966040-Humans,
pubmed-meshheading:17966040-Male,
pubmed-meshheading:17966040-Mutagenesis, Site-Directed,
pubmed-meshheading:17966040-Myeloblastin,
pubmed-meshheading:17966040-Protein Folding,
pubmed-meshheading:17966040-Recombinant Proteins,
pubmed-meshheading:17966040-Wegener Granulomatosis
|
pubmed:year |
2007
|
pubmed:articleTitle |
A study of conformational restraints on reactivity of human PR3-specific autoantibodies (ANCA) facilitated through protein folding manipulations of a new recombinant proteinase 3 protein.
|
pubmed:affiliation |
UNC Kidney Center, University of North Carolina at Chapel Hill, NC 27599, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|